A method for ascertaining whether a subject has oxidative stress;
evaluating the level of oxidative stress in a subject; reducing the risk
of an adverse event, especially an adverse cardiovascular event,
resulting from oxidative stress; treating oxidative stress; and
evaluating the efficacy of treatment with at least one pharmaceutical
composition for reducing oxidative stress is provided.
